How to Get AndroGel in Iowa

Iowa Telehealth Rules for Testosterone Prescribing

Iowa permits licensed prescribers to evaluate, diagnose, and prescribe testosterone gel through telehealth platforms, provided a valid provider-patient relationship is established. The Iowa Board of Medicine updated its telehealth rules under Iowa Administrative Code 653, Chapter 13.11, allowing synchronous audio-video consultations to satisfy the initial encounter requirement. No in-person visit is mandated before prescribing.

This matters for AndroGel access because testosterone replacement therapy (TRT) requires ongoing monitoring. The Endocrine Society's 2018 clinical practice guideline recommends measuring serum testosterone with at least two morning samples drawn before 10 a.m., along with baseline hematocrit, lipid panel, and PSA in men over 40 [1]. Telehealth providers operating in Iowa can order these labs through national networks like Quest Diagnostics or Labcorp, both of which maintain draw sites in Des Moines, Cedar Rapids, Davenport, Iowa City, and Sioux City.

A telehealth visit for TRT typically runs 15 to 25 minutes. The provider reviews symptoms (fatigue, reduced libido, depressed mood), confirms two low morning total testosterone values below 300 ng/dL per the Endocrine Society threshold, and rules out contraindications such as polycythemia (hematocrit above 50%), untreated obstructive sleep apnea, or active prostate cancer [1]. Once cleared, the prescriber sends an electronic prescription to any Iowa pharmacy or a mail-order pharmacy licensed to ship into the state.

Who Can Prescribe AndroGel in Iowa

Three categories of clinician can write an AndroGel prescription in Iowa: physicians (MD/DO), nurse practitioners, and physician assistants. The scope differs by credential.

MDs and DOs hold unrestricted prescriptive authority. Nurse practitioners in Iowa gained full practice authority under the 2021 update to Iowa Code Chapter 152E, which removed the collaborative agreement requirement after 4 to 160 hours of supervised practice. NPs who have completed this transition period can independently prescribe Schedule III controlled substances, including testosterone. Physician assistants prescribe under a supervisory agreement with a licensed physician, per Iowa Code Chapter 148C [2].

The T-Trials, a coordinated set of seven placebo-controlled studies enrolling 790 men aged 65 and older with serum testosterone below 275 ng/dL, demonstrated that testosterone gel produced improvements in sexual function, walking distance, and mood over 12 months [3]. These findings informed the Endocrine Society guideline's recommendation to consider TRT in symptomatic men with unequivocally low testosterone, regardless of whether the prescribing clinician is a physician or advanced practice provider.

Lab Requirements Before Starting AndroGel

No prescriber in Iowa should write a testosterone prescription without confirmatory lab work. The minimum panel includes two separate morning total testosterone levels, a complete blood count with hematocrit, a comprehensive metabolic panel, and a lipid profile. Men aged 40 and older also need a baseline PSA [1].

Why two draws? Testosterone levels fluctuate. A single low reading can reflect acute illness, poor sleep, or circadian variation. The Endocrine Society guideline states: "Clinicians should confirm the diagnosis by repeating the measurement of morning total testosterone" [1]. Levels should be drawn between 7 a.m. and 10 a.m. when diurnal peaks occur.

Additional labs may be warranted. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) help distinguish primary hypogonadism (testicular failure, LH elevated) from secondary hypogonadism (pituitary or hypothalamic origin, LH low or inappropriately normal). Prolactin and iron saturation can rule out prolactinoma and hemochromatosis, two treatable causes of secondary hypogonadism [4].

In the T-Trials, baseline mean total testosterone was 232 ng/dL across the cohort, and 12 months of AndroGel 1% raised levels to a mean of 469 ng/dL [3]. Monitoring labs at 3, 6, and 12 months, then annually, is the standard follow-up schedule. Hematocrit must be rechecked at each visit because testosterone stimulates erythropoiesis. If hematocrit exceeds 54%, the dose should be reduced or therapy held [1].

Iowa Medicaid Does Not Cover Brand AndroGel

Iowa Medicaid's preferred drug list does not include brand-name AndroGel for male hypogonadism. Patients enrolled in Iowa Medicaid managed care plans (Amerigroup Iowa or Iowa Total Care) may request a prior authorization exception, but approval rates for brand testosterone gel are low when generic alternatives exist.

Generic testosterone gel 1% (authorized generics and ANDA-approved products from Teva and Perrigo) is available and typically 60% to 80% less expensive than brand AndroGel. GoodRx data from May 2026 shows brand AndroGel 1.62% (pump) priced between $550 and $700 for a 30-day supply at Iowa retail pharmacies, while generic testosterone gel 1% ranges from $30 to $90 with a coupon.

Commercial insurers operating in Iowa, including Wellmark Blue Cross Blue Shield and UnitedHealthcare, generally cover generic testosterone gel with a prior authorization confirming two low testosterone results and a documented clinical diagnosis of hypogonadism (ICD-10 E29.1). The American Urological Association's 2018 guideline on testosterone deficiency notes that "testosterone therapy is indicated for men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density" [2]. Insurers reference this language when adjudicating coverage.

Prior Authorization Documentation for Iowa Insurers

Most Iowa commercial plans require prior authorization before dispensing testosterone gel. The documentation package typically includes four elements: two morning total testosterone values below the lab's reference range (usually <300 ng/dL), a signed clinician attestation of hypogonadal symptoms, ICD-10 diagnosis code E29.1 (testicular hypofunction), and proof that contraindications have been evaluated.

Wellmark's 2025 prior authorization form for testosterone products requires the prescriber to confirm that the patient does not have metastatic prostate cancer, breast cancer, hematocrit above 50% at baseline, untreated severe obstructive sleep apnea, or uncontrolled heart failure [5]. The turnaround time for standard prior authorization decisions in Iowa is 72 hours for non-urgent requests under Iowa Insurance Division rules.

If a prior authorization is denied, Iowa patients have the right to appeal. For Medicaid managed care enrollees, appeals are routed through the plan's internal review and then to the Iowa Department of Health and Human Services for an external review. For commercial plans, the Iowa Insurance Division oversees external review under Iowa Code Chapter 514J.

A 2020 analysis in JAMA Internal Medicine found that 24% of prior authorization requests for testosterone therapy were initially denied, with 40% of those denials overturned on appeal [6]. Accurate documentation at the first submission reduces delays substantially.

503A Compounding Pharmacies in Iowa

Iowa-licensed 503A compounding pharmacies can prepare individualized testosterone gel prescriptions. These pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits compounding based on a valid patient-specific prescription [7].

Compounded testosterone gel differs from FDA-approved AndroGel. The compounded version is prepared by a pharmacist in a specific concentration and base chosen by the prescriber. Common formulations include testosterone 5%, 10%, or 20% in a pentravan or PLO gel base. Compounded testosterone gel typically costs $40 to $80 per month, making it a viable option for Iowa patients without insurance coverage for brand or generic products.

Iowa Board of Pharmacy rules require 503A pharmacies to compound in compliance with USP <795> standards for non-sterile preparations. The pharmacy must hold a current Iowa license, and the compounding must be based on a prescription for an individually identified patient. Bulk compounding without patient-specific prescriptions falls under 503B outsourcing facility rules, which carry different FDA registration and reporting requirements [7].

Several compounding pharmacies in Iowa ship statewide. Patients in rural areas of western or northern Iowa, where endocrinologists and urologists are scarce, often rely on compounded testosterone prescribed via telehealth and shipped directly to their address.

Timeline from Consultation to First Application

Most Iowa patients can go from initial telehealth consultation to applying their first dose of testosterone gel within 7 to 14 days. The timeline breaks down as follows.

Day 1 to 3: schedule a telehealth visit and complete a medical intake form. Day 2 to 5: visit a local lab for morning blood draw (fasting preferred for lipid accuracy). Day 5 to 10: lab results return, provider reviews and schedules a follow-up video visit to discuss findings. Day 7 to 12: if testosterone is confirmed low on two draws and no contraindications exist, the provider sends an e-prescription. Day 8 to 14: pharmacy fills the prescription, or mail-order ships it (standard ground to Iowa addresses takes 2 to 5 business days).

Some telehealth platforms compress this timeline by accepting recent lab results. If a patient already has two qualifying testosterone draws from the past 6 months, the prescribing visit can happen on the first encounter, cutting the timeline to as few as 3 to 5 days.

AndroGel 1% is applied once daily, typically to the shoulders, upper arms, or abdomen. The FDA label specifies that the application site should not be washed for at least 2 hours and that skin-to-skin contact with women and children must be avoided due to transdermal transfer risk [5]. The starting dose is 50 mg daily (two 25 mg packets or four pumps of the 1.62% formulation), with dose adjustment based on serum testosterone measured 2 to 8 hours after application at the 14-day mark.

Transferring an AndroGel Prescription to Iowa

Patients relocating to Iowa can transfer an existing testosterone gel prescription from another state. Iowa Board of Pharmacy rules permit prescription transfers between licensed pharmacies under Iowa Administrative Code 657, Chapter 8.

The process is straightforward. The patient contacts an Iowa pharmacy and provides the out-of-state pharmacy's name, phone number, and prescription number. The receiving pharmacist calls the originating pharmacy and records the transfer details. Controlled substance transfers (testosterone is Schedule III) are limited to one transfer per prescription fill under DEA regulations, 21 CFR 1306.25, unless both pharmacies share a real-time electronic database [8].

For patients using mail-order pharmacies licensed in multiple states, no transfer may be needed. The mail-order pharmacy simply ships to the Iowa address. Patients should verify that their mail-order pharmacy holds an Iowa non-resident pharmacy license by checking the Iowa Board of Pharmacy's online license verification portal.

One consideration: a new Iowa-based provider may want to review labs and establish a local provider-patient relationship before authorizing refills. This is particularly likely if the original prescription is more than 12 months old or if monitoring labs are overdue. The Endocrine Society recommends hematocrit and testosterone level checks at 3 to 6 months after starting therapy, then annually [1].